Metsera, Inc.
MTSRDelisted Nov 13, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002040807
Metsera, Inc. was delisted on Nov 13, 2025; its insiders filed their last Form 4 on Nov 17, 2025; 155 institutions reported holding it in 13F filings for Q3 2025, worth $3.39B in total; no superinvestor held it.
Q2 2025 vs. Q1 2025
How the institutions holding Metsera, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 80 | 109 | +29 |
| Shares | 54.6M | 61.1M | +6.47M (+11.8%) |
| Value | $1.49B | $1.74B | +$249.0M (+16.7%) |
New holders (39)
Institutions that held Metsera, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (10)
Institutions that held Metsera, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Paradigm Biocapital Advisors LP | 1,191,462 | $32.4M |
| Deerfield Management Company, L.P. (Series C) | 500,000 | $13.6M |
| Braidwell LP | 175,000 | $4.76M |
| Siren, L.L.C. | 150,000 | $4.08M |
| Norges Bank | 127,442 | $3.47M |
| Millennium Management LLC | 73,698 | $2.01M |
| Schonfeld Strategic Advisors LLC | 21,395 | $582.4K |
| Ameriprise Financial Inc | 10,022 | $272.8K |
| SummitTX Capital, L.P. | 9,523 | $259.2K |
| Corebridge Financial, Inc. | 7,556 | $205.7K |